Canada markets closed

InnoCan Pharma Corporation (INNO.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.2350-0.0100 (-4.08%)
At close: 01:25PM EDT

InnoCan Pharma Corporation

1015, 926 – 5 Avenue SW
Calgary, AB T2P 0N7
403 777 1519

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Ron MayronExec. Chairman288kN/A1963
Ms. Iris BincovichCEO & Director645kN/A1969
Mr. Yoram DruckerFounder, Exec. VP of Bus. Devel. & Director398kN/A1965
Mr. Nelson Harvey Halpern F.C.A., FCPAChief Financial Officer111kN/A1959
Mr. Nir Avram B.Sc., M.Sc.Chief Technology OfficerN/AN/AN/A
Mr. Eyal Flom L.L.M., M.B.A.Director & Company Sec.N/AN/A1966
Roni KamhiChief Operating OfficerN/AN/AN/A
Mr. Moshe HukayloChief Financial Officer of InnoCan Pharma Ltd.N/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.


InnoCan Pharma Corporation, a pharmaceutical company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Poland, France, and internationally. The company engages in the research and development of COVID-19 and other condition treatment by using CBD loaded exosomes; and CBD loaded liposomes. Its product includes CBD eye serum, CBD face oil, CBD face cream, CBD facial serum, CBD sleeping mask, CBD recovery lotion, and the Relief & Go spray. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products. InnoCan Pharma Corporation was incorporated in 2018 and is headquartered in Calgary, Canada.

Corporate Governance

InnoCan Pharma Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.